AroCell Q2: First quarter with a positive cash flow - Redeye

Redeye is encouraged to see AroCell recording its first quarter with a positive cash flow, and the report solidifies our take on the coming quarters. We learn about a coming strategic overview that could entail an acquisition, but nothing concrete has been announced. We leave our base case intact and point to AroCell trading at undeservedly low EV/sales multiples.

Länk till analysen i sin helhet: https://www.redeye.se/research/1032064/arocell-q2-first-quarter-with-a-positive-cash-flow?utm_source=finwire&utm_medium=RSS